Keywords: chimerix, gains, rights, gilead, cidofovir, licensed, fellow

Chimerix gains rights to Gilead's cidofovir

Article | 22 September 2003

Print This

Chimerix has licensed rights from fellow US firm Gilead Sciences to develop oral derivatives of the latter's antiviral compound cidofovir, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in